Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

Metaphase cytogenetic abnormalities, plasma cell proliferation index (PCPro), and gain 1q by fluorescence in situ hybridization (FISH) are associated with inferior survival in newly diagnosed multiple myeloma (MM) treated with novel agents; however, their role in risk stratification is unclear in th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Autores principales: Mellors, Patrick W., Binder, Moritz, Ketterling, Rhett P., Greipp, Patricia T., Baughn, Linda B., Peterson, Jess F., Jevremovic, Dragan, Pearce, Kathryn E., Buadi, Francis K., Lacy, Martha Q., Gertz, Morie A., Dispenzieri, Angela, Hayman, Suzanne R., Kapoor, Prashant, Gonsalves, Wilson I., Hwa, Yi L., Fonder, Amie, Hobbs, Miriam, Kourelis, Taxiarchis, Warsame, Rahma, Lust, John A., Leung, Nelson, Go, Ronald S., Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2020
Materias:
Lymphoid Neoplasia
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7252538/
https://ncbi.nlm.nih.gov/pubmed/32442300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019001275
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares